Vedolizumab for the Treatment of Moderately to Severely Active Ulcerative Colitis

Publisher: John Wiley & Sons Inc

E-ISSN: 1875-9114|35|4|412-423

ISSN: 0277-0008

Source: PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol.35, Iss.4, 2015-04, pp. : 412-423

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract